logo
Select company
Select metric
$ -9.91MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
25
Sector
61
Industry
78
History
77
$ 2.1Close
$ 1.45 - $ 3.73 52-Week Range
Ticker Information

Ticker

WHWK

Company Name

WHITEHAWK THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

WHITEHAWK THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

WHWK - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 471K$ -10.38M$ -9.91M
3/31/2025$ 619K$ 27.71M$ 28.33M
12/31/2024$ 653K$ -63.54M$ -62.88M
9/30/2024$ 650K$ -61.48M$ -60.83M
6/30/2024$ 647K$ -65.21M$ -64.56M
3/31/2024$ 641K$ -68.6M$ -67.96M
12/31/2023$ 630K$ -65.53M$ -64.9M
9/30/2023$ 629K$ -63.19M$ -62.56M
6/30/2023$ 595K$ -61.36M$ -60.76M
3/31/2023$ 555K$ -61.65M$ -61.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • WHITEHAWK THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -3.98M.
  • Over the past 5 years, WHITEHAWK THERAPEUTICS INC's average EBITDA has been $ -55.23M.
  • The median EBITDA for WHITEHAWK THERAPEUTICS INC during this period was $ -61.48M
  • WHITEHAWK THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 28.33M.
  • The lowest EBITDA recorded by WHITEHAWK THERAPEUTICS INC in the same timeframe $ -134.36M

WHITEHAWK THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
HYFT : MINDWALK HOLDINGS CORP $ -19.99MIRD : OPUS GENETICS INC $ -58.24MEQ : EQUILLIUM INC $ -19.7MSRZN : SURROZEN INC $ -31.83MVRCA : VERRICA PHARMACEUTICALS INC $ -38.54MICCC : IMMUCELL CORP $ 4.47MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -60.1MSEER : SEER INC $ -75.84MGBIO : GENERATION BIO CO $ -67.79MMGX : METAGENOMI INC $ -79.73M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for WHITEHAWK THERAPEUTICS INC is calculated as follows: EBIT [ $ -4.04M ] + DepAmor [ $ 68.7K ]
(=) EBITDA [ $ -3.98M ]

WHWK - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -134.36M

Minimum

Jun 30, 2022

$ 28.33M

Maximum

Mar 31, 2025

$ -55.23M

Average

$ -61.48M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.77M with a standard deviation of $ 166.95M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.77M
median$ 8.83M
std$ 166.95M